Articles > Balsm Alofoq Medical Co. Secures Lucrative Contract with Royal Commission in Jubail
Balsm Alofoq Medical Co. Secures Lucrative Contract with Royal Commission in Jubail
By KlickAnalytics Data Insights | February 2, 2026 02:12AM ET
- The medical company signs a contract with the Royal Commission in Jubail for the operation and maintenance of primary healthcare services in Ras Al-Khair Program.
- The contract, valued at 71,809,882.21 riyals, spans over five years and is expected to have a positive financial impact in the first half of 2026.
In a groundbreaking development, Balsm Alofoq Medical Co. has officially signed a contract with the Royal Commission in Jubail to oversee the operation and maintenance of primary healthcare services within the Ras Al-Khair Program in Jubail Industrial City. This deal comes after the company's previous receipt of a letter of award for the prestigious project, marking a significant milestone in their portfolio.
The contract, valued at a whopping 71,809,882.21 riyals, is set to last for a duration of five years. Balsm Alofoq Medical Co. will be responsible for managing the primary healthcare services in Ras Al-Khair Program according to the agreed terms outlined in the contract, ensuring the seamless delivery of essential medical services to the community.
With the signing of this contract, Balsm Alofoq Medical Co. anticipates a favorable financial impact, with positive results expected to reflect in their performance during the initial half of 2026. This partnership with the Royal Commission in Jubail underscores the company's commitment to enhancing healthcare services and making a meaningful difference in the lives of the residents of Jubail Industrial City.
- The contract, valued at 71,809,882.21 riyals, spans over five years and is expected to have a positive financial impact in the first half of 2026.
In a groundbreaking development, Balsm Alofoq Medical Co. has officially signed a contract with the Royal Commission in Jubail to oversee the operation and maintenance of primary healthcare services within the Ras Al-Khair Program in Jubail Industrial City. This deal comes after the company's previous receipt of a letter of award for the prestigious project, marking a significant milestone in their portfolio.
The contract, valued at a whopping 71,809,882.21 riyals, is set to last for a duration of five years. Balsm Alofoq Medical Co. will be responsible for managing the primary healthcare services in Ras Al-Khair Program according to the agreed terms outlined in the contract, ensuring the seamless delivery of essential medical services to the community.
With the signing of this contract, Balsm Alofoq Medical Co. anticipates a favorable financial impact, with positive results expected to reflect in their performance during the initial half of 2026. This partnership with the Royal Commission in Jubail underscores the company's commitment to enhancing healthcare services and making a meaningful difference in the lives of the residents of Jubail Industrial City.
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.